Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Flossmann, O
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis? [electronic resource] - Annals of the rheumatic diseases Jul 2006 - 841-4 p. digital
Publication Type: Editorial; Review
0003-4967
10.1136/ard.2005.048900 doi
Antibodies, Antineutrophil Cytoplasmic--immunology
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
B-Lymphocytes--immunology
Humans
Immunologic Factors--therapeutic use
Lymphocyte Depletion
Remission Induction
Rituximab
Vasculitis--drug therapy
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis? [electronic resource] - Annals of the rheumatic diseases Jul 2006 - 841-4 p. digital
Publication Type: Editorial; Review
0003-4967
10.1136/ard.2005.048900 doi
Antibodies, Antineutrophil Cytoplasmic--immunology
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
B-Lymphocytes--immunology
Humans
Immunologic Factors--therapeutic use
Lymphocyte Depletion
Remission Induction
Rituximab
Vasculitis--drug therapy